Physician profile
Christopher J Forrest
NPI 1245318302
$921.01
in general payments reported to CMS, 2019-2025
7 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $11.43 · 2021: $26.48 · 2022: $120 · 2023: $119 · 2024: $231 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $196.55 | 2022-2023 | Eluvia, Jetstream Sc |
| Philips North America LLC | $154.54 | 2024-2025 | (Bq9) Coronary Ivus, (6585) Omniwire, Coronary Other |
| Shockwave Medical, INC | $144.89 | 2025 | |
| Medtronic Vascular, INC. | $144.23 | 2019-2020 | |
| Abbott Laboratories | $142.99 | 2021-2024 | Xience Skypoint, Nc Trek Neo, Diamondback Coronary |
| Abiomed | $120.30 | 2019 | |
| Terumo Medical Corporation | $17.51 | 2023 | Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Forrest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.